Skip to main content
Covering the operations of the oil and gas industry
General Interest
Refining & Processing
Drilling & Production
Exploration & Development
Pipelines & Transportation
Sections
General Interest
Refining & Processing
Drilling & Production
Exploration & Development
Pipelines & Transportation
LNG
Energy Transition
Industry Statistics
Members Only
Special
Webcasts
White Papers
Podcast
Magazine
Surveys
Research
Events
Submit an Article
Iran war
Contact
About Us
Subscribe
Newsletters
Advertise
Contact Us
Privacy Policy
Terms & Conditions
Affiliated Brands
OFFSHORE
ENERGYTECH
MICROGRID KNOWLEDGE
OGJ RESEARCH
Follow us on
http://www.facebook.com/ogjonline
https://www.linkedin.com/company/oil-&-gas-journal
http://twitter.com/ogjonline
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
PennEnergy Stock Watch
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about IONS
Recent news which mentions IONS
< Previous
1
2
3
4
5
6
7
Next >
Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2023
May 04, 2023
Tickers
ABSI
BLDR
BLKB
CERE
Tags
ABSI
BLDR
QNST
From
Benzinga
Recap: Ionis Pharmaceuticals Q1 Earnings
May 03, 2023
Tickers
IONS
Tags
IONS
Market News
Earnings
From
Benzinga
Ionis Pharmaceuticals's Earnings Outlook
May 02, 2023
Tickers
IONS
Tags
Market News
Earnings
Benzinga
From
Benzinga
Biogen's Amyotrophic Lateral Sclerosis Drug Scores Conditional Approval From FDA
April 26, 2023
Tickers
BIIB
IONS
Tags
BIIB
News
Health Care
From
Benzinga
FDA grants accelerated approval to Biogen treatment for rare form of ALS
April 25, 2023
Tickers
BIIB
IONS
Tags
IONS
BIIB
From
MarketWatch
What's Going On With Biogen Stock Tuesday?
April 25, 2023
Tickers
BIIB
IONS
Tags
IONS
Market News
Benzinga
From
Benzinga
Biogen Announces Additional Cost Cutting Initiatives, Chops Certain Stroke, Gene Therapy Programs
April 25, 2023
Tickers
BIIB
IONS
Tags
Briefs
Earnings
News
From
Benzinga
3 Biotech Stocks to Sell Before They’re 6 Feet Under
April 24, 2023
Tickers
ACRS
AMRS
IONS
Tags
ACRS
NASDAQ:AMRS,NASDAQ:ACRS,NASDAQ:IONS
Market News
From
InvestorPlace
AstraZeneca, Ionis Unveil Complete Phase 3 Data For ATTR Candidate, Says Drug Halts Disease Progression
April 24, 2023
Tickers
AZN
AZNCF
IONS
Tags
News
AZN
AZNCF
From
Benzinga
Could This Rare-Disease Drug Candidate Become a Blockbuster?
April 19, 2023
Tickers
AZN
IONS
Tags
Market News
AZN
Recent Press Releases
From
Motley Fool
Analyst Upgrades Arrowhead Pharma Citing 'Attractive Risk/Reward'
April 12, 2023
Tickers
ALNY
ARWR
IONS
MRNA
Tags
Analyst Color
Health Care
Analyst Ratings
From
Benzinga
Analyst Expectations for Ionis Pharmaceuticals's Future
April 11, 2023
Tickers
IONS
Tags
Analyst Ratings
IONS
BZI/AAR
From
Benzinga
AstraZeneca-Ionis Partnered Rare Disease Drug Data Shows Sustained Benefit; Drug Under FDA Review
March 27, 2023
Tickers
AZN
AZNCF
BXRX
IONS
Tags
IONS
BXRX
Market News
From
Benzinga
FDA Adcomm Says Benefit-Risk Profile Favor Biogen's Tofersen For Inherited Neuro Disorder
March 23, 2023
Tickers
BIIB
IONS
Tags
Benzinga
General
Biotech
From
Benzinga
Analyst Ratings for Ionis Pharmaceuticals
March 21, 2023
Tickers
IONS
Tags
Analyst Ratings
IONS
BZI/AAR
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 21, 2023
March 21, 2023
Tickers
ADC
AIZ
ALLO
ALNY
Tags
FLT
VTYX
RRC
From
Benzinga
Wall Street predicts approval for another ALS drug
March 21, 2023
Tickers
AMLX
BIIB
IONS
Tags
JP:4523
IONS
AMLX
From
MarketWatch
Biogen Triumphs In Legal Battle Regarding Tecfidera, Delaying EU Generic Erosion For Another Year
March 16, 2023
Tickers
BIIB
IONS
Tags
Benzinga
Market News
Expert Ideas
From
Benzinga
Ionis Pharmaceuticals's Earnings Outlook
February 21, 2023
Tickers
IONS
Tags
IONS
Earnings
Market News
From
Benzinga
Analyst Says Ionis' Additional Hereditary Angioedema Study Data Supports 'Highly Competitive Profile'
February 21, 2023
Tickers
IONS
Tags
Analyst Color
Analyst Ratings
Health Care
From
Benzinga
Analyst Expectations for Ionis Pharmaceuticals's Future
January 19, 2023
Tickers
IONS
Tags
Analyst Ratings
IONS
BZI/AAR
From
Benzinga
EXAS Nears Key Buy Signal in Active Biotech ETF ARKG
January 11, 2023
Tickers
ARKG
EXAS
IONS
PACB
Tags
golden crossover
ARK Invest
biotech
From
ETF Trends
The Latest Analyst Ratings for Ionis Pharmaceuticals
December 21, 2022
Tickers
IONS
Tags
Benzinga
Market News
Analyst Ratings
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 21, 2022
December 21, 2022
Tickers
ADPT
AIMC
AMV
APPN
Tags
BRKL
BLCO
ADPT
From
Benzinga
Ionis Pharmaceuticals Earnings Perspective: Return On Capital Employed
December 13, 2022
Tickers
IONS
Tags
IONS
BZI/ROCE
Benzinga
From
Benzinga
Gene Deal Adds New Dimension to Biotech ETF SBIO
November 16, 2022
Tickers
ALPS
IONS
SBIO
Tags
SS&C
IONS
SBIO
From
ETF Trends
4 Analysts Have This to Say About Ionis Pharmaceuticals
November 10, 2022
Tickers
IONS
Tags
BZI/AAR
Analyst Ratings
IONS
From
Benzinga
Phillips 66 To Rally 25%? Here Are 5 Other Price Target Changes For Thursday
November 10, 2022
Tickers
HCAT
IONS
PSX
RSKD
Tags
TTD
Price Target Changes
IONS
From
Benzinga
Ionis Regains Rights To Thrombosis Candidate From Bayer
November 04, 2022
Tickers
BAYRY
BAYZF
IONS
Tags
News
Health Care
Briefs
From
Benzinga
3 Biotech Stocks to Sell in October
September 29, 2022
Tickers
GILD
GLPG
ILMN
IONS
Tags
GLPG
ILMN
GILD
From
InvestorPlace
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.